Germany · Delayed Price · Currency is EUR Bilfinger SE Earnings Call Transcripts
Fiscal Year 2025
-
Achieved strong 2025 results with 8% revenue growth, 75% higher Free Cash Flow, and improved margins. 2026 guidance targets further growth and margin expansion, with continued focus on M&A, operational efficiency, and balanced segment exposure.
-
Ambitious targets set for 8%-10% annual growth and 8%-9% EBITDA margin by 2030, driven by operational excellence, market expansion, and digitalization. The new geography-led structure, enhanced sales focus, and disciplined M&A aim to capture expanded market opportunities and deliver strong cash flow.
-
Revenue grew 8% year-over-year in Q3 2025, with strong cash flow and improved margins. All segments contributed to growth, and guidance for the year was raised. Chemicals in Germany remain weak, but pharma, energy, and oil & gas show robust demand.
-
Record order intake and strong revenue growth drove margin and cash flow improvements, with a robust order backlog covering most of 2025 and 2026. Segment performance was solid across regions, and the company confirmed its outlook and midterm targets despite market volatility.
-
Orders and revenue grew strongly year-over-year, with improved margins and robust free cash flow. Guidance for 2025 is maintained, supported by a strong order backlog, strategic acquisitions, and regained investment grade rating.
Fiscal Year 2024
-
2024 saw double-digit growth in orders, revenue, and EBITDA margin, with strong cash flow and a proposed €2.40 dividend. Guidance for 2025 anticipates further revenue and margin growth, with risks from political uncertainty in the U.S. and Europe.
-
Q3 2024 saw strong order growth, improved margins, and robust free cash flow, with all segments contributing and the Stork acquisition performing above expectations. Guidance for 2024 is confirmed, with raised free cash flow outlook and continued progress toward midterm targets.
-
Q2 2024 delivered strong order intake, improved margins, and positive free cash flow, supported by the Stork acquisition and robust performance across segments. Full-year guidance is confirmed, with stable to positive market conditions and ongoing integration of recent acquisitions.